Gary Lee
Company: Lyell Immunopharma
Job title: Chief Scientific Officer
Seminars:
Q&A with the Modality Experts 12:00 pm
day: Focus Day Track 3
Overcoming Major Barriers of Solid Tumors with Genetic & Epigenetic Reprogramming of CAR-T cells 11:20 am
day: Focus Day Track 3